Home › Funds › Renaissance Technologies › DNTH
Renaissance Technologies position in DNTH
DIANTHUS THERAPEUTICS INC · Health Care
Latest position (Q4 2025)32.10K sh
Reported value held$1.32M
Portfolio Weight0.00%
First reportedQ3 2023
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 35.22K | $481 | New |
| Q4 2023 | 49.31K | $513 | Add |
| Q1 2024 | 105.70K | $3.17K | Add |
| Q2 2024 | 88.60K | $2.29M | Reduce |
| Q3 2024 | 55.42K | $1.52M | Reduce |
| Q4 2025 | 32.10K | $1.32M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNTH
- Fidelity Management & Research (FMR) 8.20M sh · $799.33M · Q2 2026
- BlackRock Inc 4.12M sh · $401.99M · Q2 2026
- Wellington Management Group 3.23M sh · $314.85M · Q2 2026
- Geode Capital Management 1.26M sh · $122.70M · Q2 2026
- UBS Group AG 1.14M sh · $111.15M · Q2 2026
- Franklin Resources 968.98K sh · $94.46M · Q2 2026
- Vanguard Group 2.05M sh · $84.42M · Q4 2025
- Northern Trust Corp 411.79K sh · $40.14M · Q2 2026
- Goldman Sachs Group 382.16K sh · $37.25M · Q2 2026
- Charles Schwab Investment Management 365.96K sh · $35.67M · Q2 2026
- Bank of America Corp 256.83K sh · $25.04M · Q2 2026
- BNY Mellon 256.39K sh · $24.99M · Q2 2026